References
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease2013 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdfAccessed January 2013
- SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
- MiravitllesMGuerreroTMayordomoCSanchez-AgudoLNicolauFSeguJLFactors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study GroupRespiration20006749550111070451
- NiewoehnerDELokhnyginaYRiceKRisk indexes for exacerbations and hospitalizations due to COPDChest2007131202817218552
- CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
- PuhanMAGarcia-AymerichJFreyMExpansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO indexLancet200937470471119716962
- JonesRCDonaldsonGCChavannesNHDerivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE IndexAm J Respir Crit Care Med20091801189119519797160
- RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
- No authors listedStandardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med1995152110711367663792
- Japanese Respiratory SocietyThe predicted values of spirometry and arterial blood gas analysis in JapaneseJ Jap Resp Soc200139 Appendix (In Japanese)
- MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest1988935805863342669
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function LaboratoriesATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med200216611111712091180
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis1987403733833558716
- HosmerDWLemeshowSApplied Logistic Regression2nd edHoboken, NJ, USAJohn Wiley & Sons2000
- HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med20103631128113820843247
- SundhJJansonCLisspersKStallbergBMontgomerySThe Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPDPrim Care Respir J20122129530122786813
- ChavannesNHJonesRCPostmaDSRennardSUsing COPD multidimensional indices in routine clinical practice: DOSE meets all criteriaPrim Care Respir J20122124524622836739
- FaganelloMMTanniSESanchezFFPelegrinoNRLuchetaPAGodoyIBODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary diseaseAm J Med Sci2010339101419926966
- MarinJMCarrizoSJCasanovaCPrediction of risk of COPD exacerbations by the BODE indexRespir Med200910337337819013781
- WHO Expert ConsultationAppropriate body-mass index for Asian populations and its implications for policy and intervention strategiesLancet200436315716314726171
- DonaldsonGCSeemungalTAPatelISLloyd-OwenSJWilkinsonTMWedzichaJALongitudinal changes in the nature, severity and frequency of COPD exacerbationsEur Respir J20032293193614680081
- QuintJKDonaldsonGCHurstJRGoldringJJSeemungalTRWedzichaJAPredictive accuracy of patient-reported exacerbation frequency in COPDEur Respir J20113750150720650988
- EffingTWKerstjensHAMonninkhofEMDefinitions of exacerbations: does it really matter in clinical trials on COPD?Chest200913691892319736196
- WaltersEHWaltersJWillsKERobinsonAWood-BakerRClinical diaries in COPD: compliance and utility in predicting acute exacerbationsInt J Chron Obstruct Pulmon Dis2012742743522848156
- BischoffEWBoerLMMolemaJValidity of an automated telephonic system to assess COPD exacerbation ratesEur Respir J2012391090109621920893
- CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
- TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
- NishimuraMMakitaHNagaiKAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185445222016444
- FukuchiYFernandezLKuoHPEfficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trialRespirology20111682583521539680
- IkegamiNYooBKHashimotoHJapanese universal health coverage: evolution, achievements, and challengesLancet20113781106111521885107
- WakabayashiRMotegiTYamadaKIshiiTGemmaAKidaKPresence of in-home caregiver and health outcomes of older adults with chronic obstructive pulmonary diseaseJ Am Geriatr Soc201159444921198462
- EisnerMDBlancPDOmachiTASocioeconomic status, race and COPD health outcomesJ Epidemiol Community Health201165263419854747
- HanMKCurran-EverettDDransfieldMTRacial differences in quality of life in patients with COPDChest20111401169117621636665
- LangsetmoLPlattRWErnstPBourbeauJUnderreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohortAm J Respir Crit Care Med200817739640118048806
- BurgelPRNesme-MeyerPChanezPCough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjectsChest200913597598219017866
- TeradaKMuroSSatoSImpact of gastro-oesophageal reflux disease symptoms on COPD exacerbationThorax20086395195518535116